Correction to Association of Gut Microbiome with Diabetes Mellitus and Alzheimer’s Disease in a Puerto Rican Adult Population: A Preliminary Report

by Clinical Neuropsychologist Online | Thursday, March 14, 2024 | Dementia

Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | March 14, 2024 Wiley: Alzheimer’s & Dementia: Table...

Adapting prescribing criteria for amyloid‐targeted antibodies for adults with Down syndrome

by Clinical Neuropsychologist Online | Thursday, March 14, 2024 | Dementia

Abstract Prior authorization criteria for Federal Drug Administration (FDA) approved immunotherapeutics, among the class of anti-amyloid monoclonal antibodies (mAbs), established by state drug formulary committees, are tailored for adults with late-onset...

Racial and ethnic differences in the association between depressive symptoms and cognitive outcomes in older adults: Findings from KHANDLE and STAR

by Clinical Neuropsychologist Online | Wednesday, March 13, 2024 | Dementia

Abstract INTRODUCTION Depressive symptoms are associated with higher risk of dementia, but how they impact cognition in diverse populations is unclear. METHODS Asian, Black, Latino, or White participants (n = 2227) in the Kaiser Healthy Aging and Diverse Life...

APOE ε4 is associated with decreased synaptic density in cognitively impaired participants

by Clinical Neuropsychologist Online | Wednesday, March 13, 2024 | Dementia

Abstract INTRODUCTION We aimed to investigate the effect of apolipoprotein E4 (APOE) ε4 on synaptic density in cognitively impaired (CI) participants. METHODS One hundred ten CI participants underwent amyloid positron emission tomography (PET) with 18F-florbetapir and...

Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients

by Clinical Neuropsychologist Online | Wednesday, March 13, 2024 | Dementia

Abstract INTRODUCTION White matter hyperintensities (WMH) are associated with key dementia etiologies, in particular arteriolosclerosis and amyloid pathology. We aimed to identify WMH locations associated with vascular risk or cerebral amyloid-β1-42 (Aβ42)-positive...

Adapted problem adaptation therapy for depression in mild to moderate Alzheimer’s disease dementia: A randomized controlled trial

by Clinical Neuropsychologist Online | Wednesday, March 13, 2024 | Dementia

Abstract INTRODUCTION Trials of effectiveness of treatment options for depression in dementia are an important priority. METHODS Randomized controlled trial to assess adapted Problem Adaptation Therapy (PATH) for depression in mild/moderate dementia caused by...